These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 14594349)

  • 21. Successful treatment of vancomycin-resistant Enterococcus meningitis with linezolid.
    Hachem R; Afif C; Gokaslan Z; Raad I
    Eur J Clin Microbiol Infect Dis; 2001 Jun; 20(6):432-4. PubMed ID: 11476449
    [No Abstract]   [Full Text] [Related]  

  • 22. Linezolid treatment for osteomyelitis due to vancomycin-resistant Enterococcus faecium.
    Till M; Wixson RL; Pertel PE
    Clin Infect Dis; 2002 May; 34(10):1412-4. PubMed ID: 11981739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short course of linezolid treatment for vancomycin-resistant Enterococcus faecium meningitis.
    Tsai TN; Wu CP; Peng MY; Giian CF; Lee SY; Lu JJ
    Int J Clin Pract; 2006 Jun; 60(6):740-1. PubMed ID: 16805761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid emergence of resistance to linezolid during linezolid therapy of an Enterococcus faecium infection.
    Seedat J; Zick G; Klare I; Konstabel C; Weiler N; Sahly H
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4217-9. PubMed ID: 16982791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Linezolid for the treatment of newborns infected with vancomycin-resistant Enterococcus faecium].
    Berberian G; Castro G; Fistolera S; Travaglianti M; Lopardo H; Mastroianni A; Rosanova MT
    Rev Argent Microbiol; 2009; 41(1):34-8. PubMed ID: 19391524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [In vitro susceptibility to linezolid in methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus strains].
    Efe S; Sinirtaş M; Ozakin C
    Mikrobiyol Bul; 2009 Oct; 43(4):639-43. PubMed ID: 20084917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative efficacies of daptomycin, vancomycin, and linezolid in experimental enterococcal peritonitis.
    Kajihara T; Nakamura S; Iwanaga N; Oshima K; Hirano K; Miyazaki T; Izumikawa K; Yanagihara K; Miyazaki Y; Hattori N; Kohno N; Kohno S; Mukae H
    J Infect Chemother; 2017 Jul; 23(7):498-501. PubMed ID: 28108098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vancomycin-resistant Enterococcus faecalis endocarditis: linezolid failure and strain characterization of virulence factors.
    Tsigrelis C; Singh KV; Coutinho TD; Murray BE; Baddour LM
    J Clin Microbiol; 2007 Feb; 45(2):631-5. PubMed ID: 17182759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid.
    Gonzales RD; Schreckenberger PC; Graham MB; Kelkar S; DenBesten K; Quinn JP
    Lancet; 2001 Apr; 357(9263):1179. PubMed ID: 11323048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of linezolid in liver transplant patients.
    Radunz S; Juntermanns B; Kaiser GM; Treckmann J; Mathe Z; Paul A; Saner FH
    Transpl Infect Dis; 2011 Aug; 13(4):353-8. PubMed ID: 21355969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Linezolid levels in a patient with biliary tract sepsis, severe hepatic failure and acute kidney injury on sustained low-efficiency dialysis (SLED).
    Cremaschi E; Maggiore U; Maccari C; Cademartiri C; Andreoli R; Fiaccadori E
    Minerva Anestesiol; 2010 Nov; 76(11):961-4. PubMed ID: 21102392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of different peritoneal dialysis fluids on the in vitro activity of ampicillin, daptomycin, and linezolid against Enterococcus faecalis.
    Kussmann M; Schuster L; Zeitlinger M; Pichler P; Reznicek G; Wiesholzer M; Burgmann H; Poeppl W
    Eur J Clin Microbiol Infect Dis; 2015 Nov; 34(11):2257-63. PubMed ID: 26337433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. First report of a linezolid- and vancomycin-resistant Enterococcus faecium strain in Korea.
    Bae HG; Sung H; Kim MN; Lee EJ; Koo Lee S
    Scand J Infect Dis; 2006; 38(5):383-6. PubMed ID: 16709544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Linezolid: a review of its use in the management of serious gram-positive infections.
    Perry CM; Jarvis B
    Drugs; 2001; 61(4):525-51. PubMed ID: 11324682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quinupristin-dalfopristin and linezolid: evidence and opinion.
    Eliopoulos GM
    Clin Infect Dis; 2003 Feb; 36(4):473-81. PubMed ID: 12567306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical linezolid 0.2% for the treatment of vancomycin-resistant or vancomycin-intolerant gram-positive bacterial keratitis.
    Tu EY; Jain S
    Am J Ophthalmol; 2013 Jun; 155(6):1095-1098.e1. PubMed ID: 23453280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peritoneal dialysis-related peritonitis caused by vancomycin-resistant Enterococcus faecium.
    Unal A; Agkus C; Kocyigit I; Oymak O; Utas C
    Ther Apher Dial; 2011 Feb; 15(1):115-6. PubMed ID: 21272263
    [No Abstract]   [Full Text] [Related]  

  • 38. Antimicrobial-resistant gram-positive bacteria in PD peritonitis and the newer antibiotics used to treat them.
    Salzer W
    Perit Dial Int; 2005; 25(4):313-9. PubMed ID: 16022084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful treatment of vancomycin-resistant enterococcal ventriculitis in a pediatric patient with linezolid.
    Maranich AM; Rajnik M
    Mil Med; 2008 Sep; 173(9):927-9. PubMed ID: 18816936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [In vitro activity of linezolid and dalbavancin against vancomycin-resistant enterococci].
    Aktaş G; Bozdoğan B; Derbentli S
    Mikrobiyol Bul; 2012 Jul; 46(3):359-65. PubMed ID: 22951648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.